Cough is a recognised ongoing complaint in long COVID — Post COVID-19 condition persisting after acute SARS-CoV-2 infection. When cough is the primary concern, a structured clinical evaluation and a targeted treatment approach are warranted.
Long COVID patients presenting with cough should undergo evaluation based on criteria developed for chronic cough, providing a systematic framework suited to this post-infectious setting.
Management may involve an inhaled corticosteroid-based intervention. The full details — including agent selection, dosing, and duration — are available in the complete structured protocol.
DOI: 10.3947/ic.2024.0024
For long COVID patients complaining of cough, evaluation should be considered based on criteria for chronic cough (B, IIa).
Short-term (2 - 4 weeks), high-dose inhaled corticosteroids can be considered.
View source ↗